The virus-associated human immunodeficiency virus type 1 Gag-Pol carrying an active protease domain in the matrix region is severely defective both in autoprocessing and in trans processing of gag particles
- PMID: 14972522
- DOI: 10.1016/j.virol.2003.08.043
The virus-associated human immunodeficiency virus type 1 Gag-Pol carrying an active protease domain in the matrix region is severely defective both in autoprocessing and in trans processing of gag particles
Abstract
We have previously demonstrated that a human immunodeficiency virus (HIV) chimeric Gag protein containing a partial replacement of the matrix domain by the viral protease domain (PR) could undergo autoprocessing with no virus particle production [J. Virol. 74 (2000) 3418]. To further analyze the effects of repositioned PR on virus particle production and Gag-Pol incorporation, we introduced the chimeric PR construct into a PR-negative Gag-Pol expression plasmid and coexpressed the resultant construct with a Pr55(gag) expression plasmid (pGAG) in 293T cells. Analysis indicated that the chimeric PR was similar to native PR in that both could prevent virus particle production in cotransfections with an equivalent amount of pGAG plasmid DNA, suggesting an efficient trans processing of Pr55(gag) by the chimeric PR. In cotransfections with the pGAG at a DNA ratio of 1:10 to 1:20, which resembles the normal intracellular expression ratio of Gag-Pol to Gag, Gag-Pol carrying the PR in the Gag coding region could undergo autoprocessing in cells and was incorporated into virus particles at a level about 20-40% of that of wild-type Gag-Pol. However, the incorporated chimeric Gag-Pol was unable to autocleave and unable to process the Gag particles properly, as mature particle-associated reverse transcriptase (RT) and p24(gag) proteins were barely detected. Our data strongly suggest that positioning an active HIV PR in the matrix region significantly affects the PR-mediated virus particle maturation.
Similar articles
-
Characterization of human immunodeficiency virus type 1 Pr160 gag-pol mutants with truncations downstream of the protease domain.Virology. 2004 Nov 10;329(1):180-8. doi: 10.1016/j.virol.2004.08.010. Virology. 2004. PMID: 15476885
-
Proteolytic activity of human immunodeficiency virus Vpr- and Vpx-protease fusion proteins.Virology. 1996 May 1;219(1):307-13. doi: 10.1006/viro.1996.0253. Virology. 1996. PMID: 8623547
-
Overexpression of the HIV-1 gag-pol polyprotein results in intracellular activation of HIV-1 protease and inhibition of assembly and budding of virus-like particles.Virology. 1993 Apr;193(2):661-71. doi: 10.1006/viro.1993.1174. Virology. 1993. PMID: 7681610
-
Assembly of the HIV-1 core particle.AIDS Rev. 2002 Apr-Jun;4(2):104-11. AIDS Rev. 2002. PMID: 12152518 Review.
-
The packaging and maturation of the HIV-1 Pol proteins.Curr HIV Res. 2005 Jan;3(1):73-85. doi: 10.2174/1570162052772942. Curr HIV Res. 2005. PMID: 15638725 Review.
Cited by
-
HIV-1 protease with leucine zipper fused at N-terminus exhibits enhanced linker amino acid-dependent activity.Retrovirology. 2018 Apr 14;15(1):32. doi: 10.1186/s12977-018-0413-6. Retrovirology. 2018. PMID: 29655366 Free PMC article.
-
Patients infected with CRF07_BC have significantly lower viral loads than patients with HIV-1 subtype B: mechanism and impact on disease progression.PLoS One. 2014 Dec 11;9(12):e114441. doi: 10.1371/journal.pone.0114441. eCollection 2014. PLoS One. 2014. PMID: 25502811 Free PMC article.
-
Placement of leucine zipper motifs at the carboxyl terminus of HIV-1 protease significantly reduces virion production.PLoS One. 2012;7(3):e32845. doi: 10.1371/journal.pone.0032845. Epub 2012 Mar 1. PLoS One. 2012. PMID: 22396796 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials